Drap okays marketing of CanSinoBIO vaccine
Top Story
February 18, 2021
ISLAMABAD: The Drug Regulatory Authority of Pakistan (DRAP) has granted ‘Emergency Use Approval’ to the CanSinoBIO Recombinant COVID-19 Vaccine Adenovirus Type 5 Vector (the “Ad5-nCoV”) and its marketing through private and public sectors. The approval has been granted following the communication of the results of the interim analysis of the global phase-III clinical trial of Ad5-nCoV to the Health Ministry by the Independent Data Monitoring Committee (IDMC).
The “Ad5-nCoV” has successfully met its pre-specified primary safety and efficacy criteria in the interim analysis.
There were no vaccine-related serious adverse events (SAEs) and, therefore, CanSinoBIO has been allowed by IDMC to continue to advance the global phase-III clinical trial of the Ad5-nCoV.
LONDON (dpa-AFX) - AstraZeneca PLC (AZN.L, AZN) said the OlympiA phase III trial for AstraZeneca and MSD's Lynparza will move to early primary analysis and reporting following a recommendation
Top UK Stocks to Watch: Rio Tinto shares hit record high on bumper payout
Joshua Warner February 17, 2021 9:36 AM
Rio Tinto pays its biggest dividend in its history, BAT expects profits to rise again this year, Imperial Brands gets a new CFO, Greencoat UK Wind and TP ICAP raise equity, and Signature Aviation sells its engine repair business. Share:
Top News: Rio Tinto pays biggest dividend in its history
Rio Tinto said it will pay a record dividend for 2020 after higher commodity prices allowed it book significantly higher margins and profit, sending shares to an all-time high.
The miner said revenue in the year edged up to $44.61 billion from $43.16 billion the year before, but underlying earnings before interest, tax, depreciation and amortisation jumped 13% to $23.90 billion from $21.19 billion. Net earnings jumped even higher, g
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza: IDMC recommend early analysis of OlympiA investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.